⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
European Commission (EC) Approves Henlius and Organon’s POHERDY ® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
businesswire.com
OGN
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
businesswire.com
OGN
Sun Pharma signe un accord définitif pour acquérir Organon
businesswire.com
OGN
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
globenewswire.com
OGN
XOMA
RMAX
SLNO
サンファーマ、オルガノン買収に関する正式契約を締結
businesswire.com
OGN
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?
prnewswire.com
RMAX
OGN
XOMA
REAX
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
globenewswire.com
XOMA
OGN
RMAX
SLNO
Sun Pharma acuerda la adquisición de Organon
businesswire.com
OGN
Johnson Fistel Investigates Potential Breaches of Fiduciary Duty in Connection with the Proposed Acquisition of Organon by Sun Pharmaceutical
globenewswire.com
OGN
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)
globenewswire.com
OGN